Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 165
Filter
1.
Drug Res (Stuttg) ; 66(9): 464-469, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27750360

ABSTRACT

Patients with spinal cord injury (SCI) usually develop lower urinary tract dysfunctions, including detrusor overactivity which is also known to be a risk factor for upper urinary tract dysfunction. Antimuscarinic agents, such as propiverine, have been used clinically for the treatment of detrusor overactivity. Also, propiverine has been known to possess antagonistic activity against L-type Ca2+ channels and transient receptor potential vanilloid subtype 1 (TRPV1), in addition to activity against muscarinic receptors. These mechanisms of action may contribute to improving detrusor overactivity in SCI. We therefore investigated the effects of antagonists of these mechanisms on non-voiding contraction (NVC) in SCI rats that are similar to clinical cases of detrusor overactivity, and considered whether these action mechanisms contribute to the incidence of NVC in SCI. Cystometry was performed in rats 4 weeks after spinal transection. Urinary functions were evaluated before and after intravenous administration of propiverine and specific antagonists for muscarinic receptors (atropine), L-type Ca2+ channels (verapamil), and TRPV1 (capsazepine). Propiverine markedly decreased the amplitude pressure of NVC in SCI rats, which was partially inhibited by atropine. Verapamil also suppressed the amplitude pressure of NVC to the same degree as propiverine. NVC disappeared almost completely after C-fiber desensitization, although capsazepine exerted no evident effects. These findings suggest that muscarinic receptors, L-type Ca2+ channels, and C-fiber afferent nerves contribute to the incidence of detrusor overactivity in SCI, and a drug that has multiple antagonistic effects, such as propiverine, is very effective for the treatment of lower urinary tract dysfunctions in SCI.


Subject(s)
Benzilates/antagonists & inhibitors , Spinal Cord Injuries/drug therapy , Urinary Bladder, Overactive/drug therapy , Animals , Atropine/pharmacology , Benzilates/therapeutic use , Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Female , Muscarinic Antagonists/therapeutic use , Rats , Spinal Cord Injuries/complications , Urinary Bladder/drug effects , Urinary Bladder, Overactive/complications , Verapamil/pharmacology
2.
Neuroscience ; 252: 24-34, 2013 Nov 12.
Article in English | MEDLINE | ID: mdl-23896570

ABSTRACT

We previously reported that the novel antidepressant-like effect of tipepidine may be produced at least partly through the activation of mesolimbic dopamine (DA) neurons via inhibiting G protein-coupled inwardly rectifying potassium (GIRK) channels. In this study, we investigated the action of tipepidine on DA D2 receptor-mediated GIRK currents (IDA(GIRK)) and membrane excitability in DA neurons using the voltage clamp and current clamp modes of the patch-clamp techniques, respectively. DA neurons were acutely dissociated from the ventral tegmental area (VTA) in rats and identified by the presence of the hyperpolarization-activated currents. Tipepidine reversibly inhibited IDA(GIRK) with IC50 7.0 µM and also abolished IDA(GIRK) irreversibly activated in the presence of intracellular GTPγS. Then tipepidine depolarized membrane potential and generated action potentials in the neurons current-clamped. Furthermore, the drug at 40 mg/kg, i.p. increased the number of cells immunopositive both for c-Fos and tyrosine hydroxylase (TH) in the VTA. These results suggest that tipepidine may activate DA neurons in VTA through the inhibition of GIRK channel-activated currents.


Subject(s)
Antidepressive Agents/pharmacology , Dopaminergic Neurons/drug effects , G Protein-Coupled Inwardly-Rectifying Potassium Channels/drug effects , Piperidines/pharmacology , Receptors, Dopamine D2/drug effects , Ventral Tegmental Area/drug effects , Animals , Dopaminergic Neurons/metabolism , G Protein-Coupled Inwardly-Rectifying Potassium Channels/metabolism , Immunohistochemistry , Patch-Clamp Techniques , Rats , Rats, Wistar , Receptors, Dopamine D2/metabolism , Ventral Tegmental Area/metabolism
3.
Neuroscience ; 169(1): 223-8, 2010 Aug 11.
Article in English | MEDLINE | ID: mdl-20433902

ABSTRACT

An enriched environment is known to promote structural changes in the brain and to enhance learning and memory performance in rodents. We previously reported that prenatal exposure to diethylstilbestrol (DES) impaired passive avoidance responses and increased levels of phosphorylated Ca(2+)/calmodulin-dependent protein kinase II (pCaMKII) in the hippocampus of mice. In this study, we examined whether an enriched environment affects the behavioral and neurochemical changes induced in mice prenatally exposed to DES. Male DES-exposed mice were placed in a standard or enriched environment at 3 weeks of age and subjected to behavioral testing after 3 weeks of exposure to these environments. Immunoblot analysis and 5-bromodeoxyuridine (BrdU) immunohistochemistry were then performed. In DES-exposed mice reared in an enriched environment, passive avoidance responses were significantly improved compared to those in mice reared in a standard environment. Moreover, the increase in level of pCaMKII in the hippocampus of DES-exposed mice was reversed by rearing in an enriched environment. Numbers of BrdU-positive cells in the dentate gyrus were significantly increased in normal and DES-exposed mice reared in the enriched environment compared to those in mice reared in the standard environment. These findings suggest that rearing in an enriched environment may mitigate the defects in brain function induced by prenatal exposure to endocrine disrupters such as DES.


Subject(s)
Dentate Gyrus/drug effects , Diethylstilbestrol/toxicity , Endocrine Disruptors/toxicity , Environment Design , Learning Disabilities/prevention & control , Prenatal Exposure Delayed Effects , Animals , Avoidance Learning/drug effects , Avoidance Learning/physiology , Brain-Derived Neurotrophic Factor/biosynthesis , Brain-Derived Neurotrophic Factor/genetics , Calcium-Calmodulin-Dependent Protein Kinase Type 2/biosynthesis , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Dentate Gyrus/pathology , Electroshock , Enzyme Induction/drug effects , Female , Gene Expression Regulation/drug effects , Housing, Animal , Learning Disabilities/chemically induced , Learning Disabilities/physiopathology , Male , Mice , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Pregnancy , Reaction Time
5.
Neuroscience ; 144(4): 1415-24, 2007 Feb 23.
Article in English | MEDLINE | ID: mdl-17184923

ABSTRACT

We investigated the effects of prenatal exposure to diethylstilbestrol (DES), an endocrine disrupter on learning behavior and synaptic functions. Specifically, we determined the activity of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and related kinases that play an essential role in long-term potentiation (LTP) in the hippocampus in mice that were prenatally exposed to DES. Treatment with DES resulted in increased CaMKII autophosphorylation and Ca(2+)-independent activity in the hippocampus and cortex of male mice. Impaired passive avoidance correlated with this increased CaMKII autophosphorylation, as did the enhanced early phase of LTP (E-LTP) in hippocampus. These data suggest that prenatal exposure to DES induces deficits in passive avoidance responses as a result of increased CaMKII activity and hippocampal LTP.


Subject(s)
Avoidance Learning/drug effects , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Diethylstilbestrol/adverse effects , Hippocampus/drug effects , Long-Term Potentiation/drug effects , Prenatal Exposure Delayed Effects/chemically induced , Animals , Avoidance Learning/physiology , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Environmental Exposure/adverse effects , Female , Hippocampus/enzymology , Hippocampus/physiopathology , Learning Disabilities/chemically induced , Learning Disabilities/enzymology , Learning Disabilities/physiopathology , Long-Term Potentiation/physiology , Male , Mice , Neurons/drug effects , Neurons/enzymology , Phosphorylation/drug effects , Pregnancy , Prenatal Exposure Delayed Effects/enzymology , Prenatal Exposure Delayed Effects/physiopathology
6.
Toxicol In Vitro ; 18(1): 55-61, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14630062

ABSTRACT

Influence of fetal bovine serum (FBS) on cytotoxicity induced by tri-n-butyltin (TBT), an environmental pollutant, on rat thymocytes was examined to reveal how FBS modifies TBT cytotoxicity. As the medium FBS concentration was increased from 0 to 10%, the cytotoxicity of TBT was dose-dependently reduced when the cells were incubated with 1 microM TBT for 3 h. Almost complete inhibitions of TBT-induced changes in cell viability and population of cells with exposed phosphatidylserine (cells undergoing apoptosis) were observed when the FBS concentration was 10%. Thus, the cytotoxicity induced by 3 h incubation with TBT in FBS-free medium may be different from that in medium containing 10% FBS. However, even in presence of 10% FBS, TBT at concentrations ranging from 10 to 300 nM exerted cytotoxic action on rat thymocytes when the cells were incubated with TBT for 24 h. TBT dose-dependently increased the population of shrunken cells, of which more than 30% were stained with propidium. TBT at 30 nM or more significantly increased the population of cells with hypodiploid DNA, indicating TBT-induced apoptotic cell death. Thus, in the presence of 10% FBS, the prolonged incubation (24 h) of rat thymocytes with TBT at nanomolar concentrations induced apoptosis rather than necrosis.


Subject(s)
Cell Survival/drug effects , Culture Media, Serum-Free/pharmacology , Serum Albumin, Bovine/pharmacology , Thymus Gland/drug effects , Trialkyltin Compounds/adverse effects , Animals , Annexin A5 , Apoptosis/drug effects , Cattle , Cell Count/methods , Cell Shape/drug effects , Cytodiagnosis/methods , Diploidy , Dose-Response Relationship, Drug , Propidium , Rats , Rats, Wistar , Thymus Gland/chemistry , Thymus Gland/cytology , Time Factors , Trialkyltin Compounds/antagonists & inhibitors
7.
Abdom Imaging ; 28(4): 525-30, 2003.
Article in English | MEDLINE | ID: mdl-14580096

ABSTRACT

BACKGROUND: Double contrast magnetic resonance (MR) imaging using superparamagnetic iron oxide (SPIO) and gadolinium (Gd) is performed to detect and characterize focal liver lesions. However, this technique is a costly and lengthy process. The purpose of this study was to determine the usefulness of SPIO-enhanced MR imaging including SPIO-enhanced T1-weighted imaging in diagnosing focal liver lesions. METHODS: Eighty-four focal liver lesions were examined with a 1.5-T MR unit. Transverse precontrast T1- and T2-weighted images and SPIO (ferumoxides)-enhanced T1- and T2-weighted images were obtained, followed by Gd-enhanced T1 -weighted imaging. The Gd set (i.e., precontrast T1- and T2-weighted and delayed-phase gadolinium-enhanced T1-weighted images) and ferumoxides set (i.e., precontrast T1- and ferumoxides-enhanced T1- and T2-weighted images) were reviewed by two independent readers. RESULTS: More lesions were detected from the ferumoxides set than from the Gd set. Ferumoxides-enhanced T1-weighted imaging showed enhancement patterns of the lesions similar to those of delayed-phase Gd-enhanced T1-weighted imaging. The diagnoses of hepatic metastasis and cyst by the ferumoxides set were similar to those by the Gd set. However, a dynamic study may be inevitable for the diagnosis of hepatocellular carcinoma and hemangioma. CONCLUSION: The ferumoxides set was useful for the detection of focal hepatic lesions. Ferumoxides-enhanced T1-weighted imaging may replace delayed-phase gadolinium-enhanced T1-weighted imaging in the diagnosis of hepatic metastasis and cysts.


Subject(s)
Gadolinium DTPA , Iron , Liver Neoplasms/diagnosis , Magnetic Resonance Imaging/methods , Oxides , Carcinoma, Hepatocellular/diagnosis , Contrast Media , Cysts/diagnosis , Dextrans , Female , Ferrosoferric Oxide , Hemangioma/diagnosis , Humans , Liver/pathology , Liver Neoplasms/secondary , Magnetite Nanoparticles , Male , Middle Aged , Suspensions
8.
Neuroscience ; 105(3): 785-91, 2001.
Article in English | MEDLINE | ID: mdl-11516842

ABSTRACT

The action of bradykinin on neurons acutely isolated from airway parasympathetic ganglia of rats and its mechanism were investigated using the nystatin-perforated patch-clamp recording technique. Under current clamp conditions, an application of 0.1 microM bradykinin onto rat airway ganglion neurons induced a depolarization which was accompanied by the action potential firing. Bradykinin elicited inward currents with decreasing the membrane conductance when a ganglion neuron was held at a holding potential of -40 mV. The half-maximum effective concentration was 8.9 nM. The bradykinin response was mimicked by a B(2) receptor agonist, [Hyp(3)]-bradykinin, and was inhibited by HOE-140, a B(2) antagonist, suggesting the contribution of B(2) receptors. The bradykinin-induced inward current reversed at the K(+) equilibrium potential, which shifted 56.5 mV with a 10-fold change in extracellular K(+) concentration. The application of 10(-3) M Ba(2+) induced the inward current, and bradykinin failed to evoke a further inward current in the presence of Ba(2+). Bradykinin also reduced the amplitude of M-current deactivation induced by a hyperpolarizing step from a holding potential of -25 mV to -50 mV with a half-maximum effective concentration of 16 nM. Pretreatment with pertussis toxin had no effect on the bradykinin-induced inhibition of the M-current. From these results we suggest that bradykinin may be able to depolarize the airway parasympathetic ganglion neurons of rats associated with an inhibition of M-type K(+) channels through the B(2) type of bradykinin receptors.


Subject(s)
Action Potentials/drug effects , Bradykinin/pharmacology , Bronchoconstriction/drug effects , Ganglia, Parasympathetic/drug effects , Neurons/drug effects , Potassium Channel Blockers , Trachea/innervation , Action Potentials/physiology , Animals , Barium/pharmacology , Bradykinin/metabolism , Bradykinin Receptor Antagonists , Bronchoconstriction/physiology , Cells, Cultured/cytology , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Ganglia, Parasympathetic/cytology , Ganglia, Parasympathetic/metabolism , Neurons/cytology , Neurons/metabolism , Patch-Clamp Techniques , Pertussis Toxin , Potassium Channels/metabolism , Rats , Rats, Wistar , Receptors, Bradykinin/agonists , Receptors, Bradykinin/metabolism , Trachea/metabolism , Virulence Factors, Bordetella/pharmacology
9.
Yakugaku Zasshi ; 121(8): 631-6, 2001 Aug.
Article in Japanese | MEDLINE | ID: mdl-11523123

ABSTRACT

For the appropriate use of drugs for injection, injection dispensing by pharmacists has been initiated at various institutions. With this movement, automatic injection dispensers have actively been developed. In our hospital, an injection order system was connected with an automatic injection dispenser in November, 1997, and this integrated system has been operating in all wards. However, the efficiency of dispensing work was not satisfactory because there were limitations in the types and volume of drugs placed in the automatic injection dispenser. Therefore, we constructed an automatic injection dispenser system that allows us to use more than 100 ml infusion fluids and also to use drugs stored in a cool place, which could not be used in the conventional system. In the new system, two trays coming from an ampoulevial line and an infusion fluid line are automatically coordinated using a discharge lifter for each patient and transported into an injection cart. After the introduction of this system, the automatic dispenser utilization rate in terms of the number of used injections increased from 52.6% to 73.3%. In addition, since the dispensing time for infusion fluids and drugs stored in a cool place, which had been collected by man power, was reduced, it became possible to pay more attention to checking for prescription.


Subject(s)
Injections/instrumentation , Technology, Pharmaceutical/instrumentation , Drug Prescriptions , Drug Storage , Humans , Pharmaceutical Solutions
10.
Nihon Shokakibyo Gakkai Zasshi ; 98(6): 636-43, 2001 Jun.
Article in Japanese | MEDLINE | ID: mdl-11436280

ABSTRACT

Enteral intake of non-metabolic monosacharide and disaccharide, followed by measurement of the urinary excretion ratio of the two, is a method used to investigate intestinal permeability. L/R ratio (lactulose/1-rhamnose urinary excretion ratio) is considered an indicator of permeability of the small intestine. An increased L/R ratio is caused by mucosal disorders of the small intestine. The L/R ratio in all patients (n = 92) with Crohn's disease was 0.079 +/- 0.081 (mean +/- S.D.), which was significantly higher than the value in normal controls (0.027 +/- 0.009, n = 20, p < 0.05). In 39 patients with Crohn's disease, we assessed intestinal permeability before after treatment with an elemental diet, and during remission. The L/R ratio was 0.120 +/- 0.092, before treatment and 0.065 +/- 0.097 after treatment (p < 0.05), showing increased intestinal permeability before elemental dietary treatment. During remission, the L/R ratio was 0.035 +/- 0.028; this did not differ significantly from the value obtained after treatment. We conclude that intestinal permeability is useful for investigating disease activity in patients with Crohn's disease.


Subject(s)
Crohn Disease/diet therapy , Crohn Disease/metabolism , Intestinal Mucosa/metabolism , Adolescent , Adult , Female , Food, Formulated , Gastrointestinal Agents/pharmacokinetics , Humans , Lactulose/pharmacokinetics , Male , Middle Aged , Permeability , Rhamnose/pharmacokinetics
11.
Dev Growth Differ ; 43(3): 257-63, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11422291

ABSTRACT

The precise expression patterns of two IgLON genes, CEPU-1 and limbic system-associated membrane protein (LAMP), were studied during early embryogenesis. It was found that expression of both was localized to restricted regions of the brain and neural crest. In the developing neural tube, CEPU-1 was expressed in the isthmus and a restricted region of the hindbrain, whereas LAMP was expressed in the anterior midbrain. Most neural crest cells expressed LAMP, whereas CEPU-1 expression was limited to crest cells derived from the hindbrain. These results suggest that members of the IgLON family have important roles during embryogenesis, particularly in brain formation and differentiation.


Subject(s)
Avian Proteins , Brain/embryology , Cell Adhesion Molecules, Neuronal/metabolism , Immunoglobulins/metabolism , Membrane Glycoproteins/metabolism , Nerve Tissue Proteins/metabolism , Neural Crest/embryology , Neurons/metabolism , Animals , Brain/metabolism , Cell Adhesion Molecules, Neuronal/genetics , Chick Embryo , GPI-Linked Proteins , Immunoglobulins/genetics , Immunohistochemistry , In Situ Hybridization , Membrane Glycoproteins/genetics , Multigene Family , Nerve Tissue Proteins/genetics , Neural Crest/cytology , Neural Crest/metabolism
12.
Life Sci ; 68(21): 2361-71, 2001 Apr 13.
Article in English | MEDLINE | ID: mdl-11350007

ABSTRACT

The interaction between beta-adrenergic signaling and the activation of protein kinase C in alveolar type II cell plays an important role in the regulation of surfactant secretion because the combined application of beta-adrenergic agonist with protein kinase C activator to the cells stimulates the secretion synergistically. However, the mechanisms underlying the interaction are not clear. In the present study, we examined the combined effect of terbutaline with phorbol 12-myristate 13-acetate (PMA) on cytoplasmic free Ca2+ concentration ([Ca2+]i) in rat alveolar type II cells. The combined application of terbutaline with PMA to the cells rapidly increased [Ca2+]i, although neither of them affected it by itself. Similar increases of [Ca2+]i were observed in other combinations, such as terbutaline with 1-oleoyl-2-acetyl-sn-glycerol, and forskolin with PMA. Either the removal of extracellular Ca2+ or the addition of Co2+ remarkably suppressed the increase of [Ca2+]i induced by the combination of terbutaline with PMA. In addition, Co2+ inhibited the phosphatidylcholine secretion induced by the combination of terbutaline and PMA. These results suggested that the [Ca2+]i increased as a result of the interaction between formation of cyclic AMP and activation of protein kinase C in alveolar type II cells, and that the increase in [Ca2+]i was mediated by the Ca2+ influx through the plasma membrane. This mechanism to modulate [Ca2+]i may play a role in the regulation of surfactant secretion by alveolar type II cells.


Subject(s)
Calcium/metabolism , Protein Kinase C/metabolism , Pulmonary Alveoli/metabolism , Receptors, Adrenergic, beta/metabolism , Signal Transduction/physiology , Adenosine Triphosphate/pharmacology , Adrenergic beta-Agonists/pharmacology , Animals , Cells, Cultured , Cobalt/pharmacology , Colforsin/pharmacology , Cyclic AMP/metabolism , Cytoplasm/drug effects , Cytoplasm/metabolism , Diglycerides/pharmacology , Drug Interactions , Epithelial Cells/cytology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Male , Phosphatidylcholines/metabolism , Pulmonary Alveoli/cytology , Pulmonary Alveoli/drug effects , Rats , Rats, Wistar , Signal Transduction/drug effects , Specific Pathogen-Free Organisms , Terbutaline/pharmacology , Tetradecanoylphorbol Acetate/pharmacology
13.
Acta Radiol ; 42(1): 27-32, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11167328

ABSTRACT

PURPOSE: Contrast-enhanced T1-weighted black-blood fast spin-echo MR imaging (BB-FSE) was performed to suppress enhancing venous signal and flow artifacts in the brain without sacrificing the T1-weighted imaging contrast. MATERIAL AND METHODS: Twenty-five MR imaging sections (17 transverse and 8 coronal images) in 15 patients with various brain diseases were obtained by contrast-enhanced T1-weighted SE and BB-FSE images. RESULTS: In contrast-enhanced T1-weighted BB-FSE images, venous signal was significantly less and T1-weighted contrast of the brain was more evident. No differences in flow artifacts were found between the two imaging techniques. The interobserver agreements were good for the venous signal and flow artifacts using both techniques. CONCLUSION: Contrast-enhanced T1-weighted BB-FSE imaging reduced the venous signal in the brain with maintaining T1-weighted contrast. This novel MR technique can be used when the suppression of enhancing venous signal is expected to improve the depiction of enhancing lesions in the brain.


Subject(s)
Artifacts , Brain Diseases/diagnosis , Brain/blood supply , Cerebral Veins , Contrast Media/administration & dosage , Cranial Sinuses , Echo-Planar Imaging/methods , Adult , Aged , Brain Diseases/physiopathology , Cerebral Veins/physiopathology , Cranial Sinuses/physiopathology , Diagnosis, Differential , Female , Gadolinium/administration & dosage , Humans , Injections, Intravenous , Male , Middle Aged , Observer Variation , Regional Blood Flow
14.
Br J Pharmacol ; 132(2): 461-6, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11159695

ABSTRACT

1. The effect of ophiopogonin-D (OP-D), a steroidal glycoside and an active component of Bakumondo-to, a Chinese herbal antitussive, on neurones acutely dissociated from paratracheal ganglia of 2-week-old Wistar rats was investigated using the nystatin-perforated patch recording configuration. 2. Under current-clamp conditions, OP-D (10 microM) hyperpolarized the paratracheal neurones from a resting membrane potential of -65.7 to -73.5 mV. 3. At the concentration of 1 microM and above, OP-D concentration-dependently activated an outward current accompanied by an increase in the membrane conductance under voltage-clamp conditions at a holding potential of -40 mV. 4. The reversal potential of the OP-D-induced current (I(OP-D)) was -79.4 mV, which is close to the K(+) equilibrium potential of -86.4 mV. The changes in the reversal potential for a 10 fold change in extracellular K(+) concentration was 53.1 mV, indicating that the current was carried by K(+). 5. The I(OP-D) was blocked by an extracellular application of 1 mM Ba2+ by 59.0%, but other K(+) channel blockers, including 4-aminopyridine (3 mM), apamin (1 microM), charybdotoxin (0.3 microM), glibenclamide (1 microM), tolbutamide (0.3 mM) and tetraethylammonium (10 mM), did not inhibit the I(OP-D). 6. OP-D also inhibited the ACh- and bradykinin-induced depolarizing responses which were accompanied with firing of action potentials. 7. The results suggest that OP-D may be of benefit in reducing the excitability of airway parasympathetic ganglion neurones and consequently cholinergic control of airway function and further, that the hyperpolarizing effect of OP-D on paratracheal neurones via an activation of K(+) channels might explain a part of mechanisms of the antitussive action of the agent.


Subject(s)
Neurons/drug effects , Potassium Channels/agonists , Saponins/pharmacology , Spirostans , Trachea/innervation , Action Potentials/drug effects , Animals , Barium/pharmacology , Electrophysiology , Ganglia, Parasympathetic/cytology , Ganglia, Parasympathetic/drug effects , Ganglia, Parasympathetic/physiology , Male , Membrane Potentials/drug effects , Parasympathetic Nervous System/cytology , Parasympathetic Nervous System/drug effects , Parasympathetic Nervous System/physiology , Patch-Clamp Techniques , Rats , Rats, Wistar , Trachea/drug effects
15.
Article in Japanese | MEDLINE | ID: mdl-11769567

ABSTRACT

Based on epidemiological studies and animal studies, endocrine disrupters have received considerable attention as exerting disrupting actions on the developing brain. On the other hand, there has been increasing evidence that sex hormones and thyroid hormones play important roles in the development of the brain, including sexual dimorphism during the perinatal stage. Thus it seems probable that perinatal exposure to endocrine disruptors, which may have an affect on biosynthesis, transport, action, and metabolism of the hormones, may disrupt brain development enough to impair the brain functions. In this review, we introduce the current state of studies on brain disrupting actions of endocrine disruptors, addressing their actions on the estrogen system, including our own findings. The outline of the findings thus far reported are as follows: (1) Perinatal exposure to relatively low concentrations of endocrine disrupters may cause an impairment of higher brain functions, such as sexual behavior and learning behavior, (2) There seems to be sexual difference about the impairment described above, (3) Endocrine disruptors may cause an increase in volume of some nuclei, such as the sexual dimorphic nucleus of the preoptic area and locus coeruleus of the brain, (4) The disruptor might change the level of some substances that are considered to be involved in synaptic functions. Much remained to be studied about how does each finding reported link the others, and about detailed mechanisms of the disrupting actions of endocrine disruptors on the developing brain.


Subject(s)
Endocrine Glands/drug effects , Environmental Pollutants/pharmacology , Receptors, Estrogen/physiology , Animals , Brain Chemistry/radiation effects , Environmental Exposure , Receptors, Estrogen/drug effects
16.
Jpn J Pharmacol ; 84(2): 225-8, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11128047

ABSTRACT

The effect of a synthetic estrogen, diethylstilbestrol (DES), on kainate-induced currents was investigated in the hippocampal CA1 pyramidal neurons acutely dissociated from the mice using the nystatin-perforated patch-clamp recording configuration under voltage-clamp conditions. DES inhibited the current evoked by 100 microM kainate in a concentration-dependent manner with a half-maximum inhibitory concentration of 8.8 microM. The action of DES was voltage-independent. Since DES produced a suppression of the maximum response of the kainate concentration-response curve, the inhibition by DES of the kainate-induced current appears to be non-competitive.


Subject(s)
Diethylstilbestrol/pharmacology , Excitatory Amino Acid Agonists/pharmacology , Hippocampus/drug effects , Kainic Acid/pharmacology , Neurons/drug effects , Animals , Drug Interactions , Electrophysiology , Estrogens, Non-Steroidal/pharmacology , Hippocampus/physiology , In Vitro Techniques , Kainic Acid/antagonists & inhibitors , Mice , Neurons/physiology , Patch-Clamp Techniques
17.
Neuropharmacology ; 39(12): 2302-8, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10974313

ABSTRACT

The effect of dextromethorphan (DM) on the inwardly rectifying K(+) currents mediated by 5-HT(1A) receptors in acutely dissociated dorsal raphe (DR) neurones of rats was studied using nystatin-perforated patch and conventional whole-cell patch recording configurations under voltage-clamp conditions. DM rapidly and reversibly inhibited the K(+) currents induced by 10(-7) M 5-HT in a concentration-dependent manner with a half-maximum inhibitory concentration of 1.43 x 10(-5) M. The inhibitory effect of DM was neither voltage- nor use-dependent. DM caused a suppression of the maximum response of the 5-HT concentration-response curve, thus suggesting a non-competitive type of inhibition. In neurones perfused intracellularly with a pipette-solution containing the nonhydrolyzable GTP analog GTPgammaS, 5-HT activated K(+) currents in an irreversible manner. DM suppressed the current irreversibly activated by intracellular GTPgammaS even in the absence of the agonist. DM also inhibited the inwardly rectifying K(+) currents regulated by alpha(2)-adrenoceptors in freshly isolated rat locus coeruleus neurones. These results suggest that DM may inhibit the G-protein coupled inwardly rectifying K(+) channels, but not the neurotransmitter receptors, in the central nervous system.


Subject(s)
Dextromethorphan/pharmacology , Neurons/metabolism , Potassium Channel Blockers , Raphe Nuclei/cytology , Receptors, Serotonin/drug effects , Serotonin Antagonists/pharmacology , Animals , Electrophysiology , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , In Vitro Techniques , Ionophores/pharmacology , Locus Coeruleus/cytology , Locus Coeruleus/drug effects , Neurons/drug effects , Nystatin/pharmacology , Patch-Clamp Techniques , Potassium Channels/metabolism , Raphe Nuclei/drug effects , Rats , Receptors, Adrenergic, alpha-2/drug effects , Receptors, Serotonin, 5-HT1
18.
Forensic Sci Int ; 113(1-3): 189-92, 2000 Sep 11.
Article in English | MEDLINE | ID: mdl-10978623

ABSTRACT

To develop a method for the determination of pancreas injuries using a pancreas-specific antigen as a marker, human elastase III was purified from the pancreas by chromatographic methods. A rabbit anti-human elastase III antibody was prepared, and this antibody was confirmed using immunoblotting to react only with elastase III among proteins from the pancreas. A sensitive sandwich enzyme immunoassay for human elastase III was developed. The detection limit for human elastase III was 0.3 pg (10 amol) per assay. Proteins extracted from the pancreas showed the strongest response, whereas reactions of the other organs were less than the detection limit. These results suggest that a sandwich enzyme immunoassay for human elastase III is useful for the determination of pancreas injury.


Subject(s)
Immunoenzyme Techniques/methods , Pancreas/enzymology , Pancreas/injuries , Pancreatic Elastase/analysis , Pancreatic Elastase/isolation & purification , Animals , Chromatography/methods , Electrophoresis, Polyacrylamide Gel/methods , Humans , Immunoblotting/methods , Pancreatic Elastase/classification , Rabbits , Sensitivity and Specificity
19.
Am J Forensic Med Pathol ; 21(2): 138-43, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10871128

ABSTRACT

The maternity of two newborns who were murdered and abandoned >5 and 10 years were analyzed by amplification and direct sequencing of mitochondrial DNA (mtDNA) control regions. Sequences of two hypervariable segments from each femur bone sample and the blood of the putative mother showed four mutations in hypervariable region I and two mutations in addition to two nucleotide insertions in hypervariable region II compared with the reference sequence, and all sequences were identical. The genotype of these individuals is found to be relatively rare in the Japanese population, and it was strongly suggested that both sets of newborn remains really were children of the putative mother. Sexes of the remains were determined to be female and male by amplifying a segment of the X-Y homologous gene, amelogenin. These results demonstrate that sequencing of mtDNA is a useful tool for genetic identification of aged and decomposed materials.


Subject(s)
DNA, Mitochondrial/genetics , Forensic Anthropology , Infanticide , Mothers , Mutation , Sequence Analysis, DNA , Amelogenin , Asian People/genetics , Autopsy , DNA Primers , DNA, Mitochondrial/blood , DNA, Mitochondrial/chemistry , Dental Enamel Proteins/genetics , Female , Femur/chemistry , Femur/pathology , Forensic Anthropology/methods , Forensic Medicine/methods , Humans , Infant, Newborn , Japan , Male , Middle Aged , Polymerase Chain Reaction
20.
Brain Res ; 854(1-2): 6-10, 2000 Jan 31.
Article in English | MEDLINE | ID: mdl-10784100

ABSTRACT

The effect of a dihydropyridine Ca2+ antagonist, cilnidipine, on voltage-dependent Ca2+ channels was studied in acutely dissociated rat CA1 pyramidal neurons using the nystatin-perforated patch recording configuration under voltage-clamp conditions. Cilnidipine had no effect on low-voltage-activated (LVA) Ca2+ channels at the low concentrations under 10(-6) M. On the other hand, cilnidipine inhibited the high-voltage-activated (HVA) Ca2+ current (I(Ca)) in a concentration-dependent manner and the inhibition curve showed a step-wise pattern; cilnidipine selectively reduced only L-type HVA I(Ca) at the low concentrations under 10(-7) and 10(-6) M cilnidipine blocked not only L- but also N-type HVA I(Ca). At the high concentration over 10(-6) M cilnidipine non-selectively blocked the T-type LVA and P/Q- and R-type HVA Ca2+ channels. This is the first report that cilnidipine at lower concentration of 10(-6) M blocks both L-and N-type HVA I(Ca) in the hippocampal neurons.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/drug effects , Calcium Channels, N-Type/drug effects , Dihydropyridines/pharmacology , Hippocampus/metabolism , Pyramidal Cells/metabolism , Animals , Calcium Channels, L-Type/physiology , Calcium Channels, N-Type/physiology , Electrophysiology , Hippocampus/cytology , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...